Publication:

PD-1 checkpoint inhibition enhances the antilymphoma activity of CD19-CAR-iNKT cells that retain their ability to prevent alloreactivity

Date

Date

Date
2024
Journal Article
Published version

Citations

Citation copied

Moraes Ribeiro, E., Secker, K.-A., Nitulescu, A.-M., Schairer, R., Keppeler, H., Wesle, A., Schmid, H., Schmitt, A., Neuber, B., Chmiest, D., Podavini, S., Märklin, M., Klimovich, B., Schmitt, M., Korkmaz, F., Lengerke, C., Schneidawind, C., & Schneidawind, D. (2024). PD-1 checkpoint inhibition enhances the antilymphoma activity of CD19-CAR-iNKT cells that retain their ability to prevent alloreactivity. Journal for ImmunoTherapy of Cancer, 12(1), e007829. https://doi.org/10.1136/jitc-2023-007829

Abstract

Abstract

Abstract

BACKGROUND

Relapse and graft-versus-host disease (GVHD) are the main causes of death after allogeneic hematopoietic cell transplantation (HCT). Preclinical murine models and clinical data suggest that invariant natural killer T (iNKT) cells prevent acute and chronic GVHD. In addition, iNKT cells are crucial for efficient immune responses against malignancies and contribute to reduced relapse rates after transplantation. Chimeric antigen receptors (CAR) redirect effector cells to cell surface antigens and enhance killing of target cel

Metrics

Downloads

8 since deposited on 2024-11-12
5last week
Acq. date: 2025-11-13

Views

39 since deposited on 2024-11-12
38last week
Acq. date: 2025-11-13

Additional indexing

Creators (Authors)

  • Moraes Ribeiro, Emmanuelle
    affiliation.icon.alt
  • Secker, Kathy-Ann
    affiliation.icon.alt
  • Nitulescu, Ana-Maria
    affiliation.icon.alt
  • Schairer, Rebekka
    affiliation.icon.alt
  • Keppeler, Hildegard
    affiliation.icon.alt
  • Wesle, Anton
    affiliation.icon.alt
  • Schmid, Hannes
    affiliation.icon.alt
  • Schmitt, Anita
    affiliation.icon.alt
  • Neuber, Brigitte
    affiliation.icon.alt
  • Chmiest, Daniela
    affiliation.icon.alt
  • Podavini, Silvia
    affiliation.icon.alt
  • Märklin, Melanie
    affiliation.icon.alt
  • Klimovich, Boris
    affiliation.icon.alt
  • Schmitt, Michael
    affiliation.icon.alt
  • Korkmaz, Fulya
    affiliation.icon.alt
  • Lengerke, Claudia
    affiliation.icon.alt
  • Schneidawind, Corina
    affiliation.icon.alt
  • Schneidawind, Dominik
    affiliation.icon.alt

Journal/Series Title

Journal/Series Title

Journal/Series Title

Volume

Volume

Volume
12

Number

Number

Number
1

Page range/Item number

Page range/Item number

Page range/Item number
e007829

Item Type

Item Type

Item Type
Journal Article

Dewey Decimal Classifikation

Dewey Decimal Classifikation

Dewey Decimal Classifikation

Language

Language

Language
English

Publication date

Publication date

Publication date
2024-01-31

Date available

Date available

Date available
2024-11-12

Publisher

Publisher

Publisher

ISSN or e-ISSN

ISSN or e-ISSN

ISSN or e-ISSN
2051-1426

OA Status

OA Status

OA Status
Gold

Free Access at

Free Access at

Free Access at
DOI

PubMed ID

PubMed ID

PubMed ID

Metrics

Downloads

8 since deposited on 2024-11-12
5last week
Acq. date: 2025-11-13

Views

39 since deposited on 2024-11-12
38last week
Acq. date: 2025-11-13

Citations

Citation copied

Moraes Ribeiro, E., Secker, K.-A., Nitulescu, A.-M., Schairer, R., Keppeler, H., Wesle, A., Schmid, H., Schmitt, A., Neuber, B., Chmiest, D., Podavini, S., Märklin, M., Klimovich, B., Schmitt, M., Korkmaz, F., Lengerke, C., Schneidawind, C., & Schneidawind, D. (2024). PD-1 checkpoint inhibition enhances the antilymphoma activity of CD19-CAR-iNKT cells that retain their ability to prevent alloreactivity. Journal for ImmunoTherapy of Cancer, 12(1), e007829. https://doi.org/10.1136/jitc-2023-007829

Gold Open Access
Loading...
Thumbnail Image

Files

Files

Files
Files available to download:1

Files

Files

Files
Files available to download:1
Loading...
Thumbnail Image